J Physiol Society Meetings
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 579, Number 1, 147-160, February 15, 2007 DOI: 10.1113/jphysiol.2006.124222
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
579/1/147    most recent
jphysiol.2006.124222v2
jphysiol.2006.124222v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antoons, G.
Right arrow Articles by Sipido, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antoons, G.
Right arrow Articles by Sipido, K. R.
Related Collections
Right arrow Cardiovascular

CARDIOVASCULAR

Window Ca2+ current and its modulation by Ca2+ release in hypertrophied cardiac myocytes from dogs with chronic atrioventricular block

Gudrun Antoons1,3, Paul G. A. Volders2, Tania Stankovicova1,4, Virginie Bito1, Milan Stengl2,3,5, Marc A. Vos2,3 and Karin R. Sipido1

1 Laboratory of Experimental Cardiology, University of Leuven, Belgium
2 Department of Cardiology, Academic Hospital Maastricht, The Netherlands
3 Department of Medical Physiology, University Medical Center, Utrecht, The Netherlands
4 Department of Pharmacology and Toxicology, Comenius University, Bratislava, Slovakia
5 Department of Physiology, Charles University, Medical School Plzen, Czech Republic


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Torsades de pointes (TdP) ventricular tachycardia typically occurs in the setting of early afterdepolarizations; it contributes to arrhythmias and sudden death in congenital and acquired heart disease. Window L-type Ca2+ current (ICaL) has a central role in the arrhythmogenesis and may be particularly important under beta-adrenergic stimulation. We studied the properties of ICaL in myocytes from the dog with chronic atrioventricular block (cAVB) that has cardiac hypertrophy and an increased susceptibility to TdP. Peak ICaL densities at baseline (K+- and Na+-free solutions, 10 mmol l–1 [EGTA]pip) in cAVB were comparable to control, but inactivation was shifted to the right, resulting in a larger window current area in cAVB. Under beta-adrenergic stimulation, the window current area was increased and shifted to the left, but less so in cAVB (maximum at –27 mV, versus –32 mV in control). ICaL during a step to –35 mV showed a transient reduction immediately after the peak. Test steps to 0 mV, simultaneous recording of [Ca2+]i and manipulation of sarcoplasmic reticulum (SR) Ca2+ release showed that this resulted from inhibition and fast recovery of ICaL with SR Ca2+ release. The extent of this dynamic modulation was larger in cAVB than in control (23 ± 2% of the initially available current, versus 13 ± 3%; P < 0.05). Early afterdepolarizations (EADs) in cAVB myocytes under beta-adrenergic stimulation typically occurred in the window current voltage range and after decline of [Ca2+]i. In conclusion, in cAVB, the larger window current, its rightward shift and enhanced dynamic modulation by SR Ca2+ release may contribute to an increased incidence of EADs in cAVB under beta-adrenergic stimulation.

(Received 3 November 2006; accepted after revision 24 November 2006; first published online 30 November 2006)
Corresponding author K. R. Sipido: Laboratory of Experimental Cardiology, KUL, Campus Gasthuisberg O/N 7th floor, Herestraat 49, B-3000 Leuven, Belgium. Email: Karin.Sipido{at}med.kuleuven.ac.be


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Torsades-de-pointes (TdP)-type ventricular arrhythmias typically occur in the setting of heterogeneous action potential prolongation and early afterdepolarizations (EADs) (Yan et al. 2001; Antzelevitch & Shimizu, 2002; Vos & Paulussen, 2004). The disturbed repolarization occurring with cardiac remodelling in hypertrophy and heart failure increases the risk for arrhythmias related to afterdepolarizations (Pogwizd et al. 1992; Tomaselli et al. 1994; Janse, 2004) and increased adrenergic drive is often the triggering event (Zipes & Wellens, 1998).

Previous studies on the mechanisms of EADs implicate reactivation of L-type Ca2+ current, ICaL, during prolonged repolarization (January & Riddle, 1989), or of Na+ currents in conditions of abnormal Na+ channel activity (Boutjdir et al. 1994; Studenik et al. 2001). Under beta-adrenergic stimulation, the shift of gating mode of Ca2+ channels into the high activity mode two facilitates EADs (Tanskanen et al. 2005). Furthermore, Ca2+ release from the sarcoplasmic reticulum is an important modulator of Ca2+ current through inactivation (Puglisi et al. 1999; Sham et al. 1995) and subsequent recovery from release-dependent inactivation (Sipido et al. 1995). Na+–Ca2+ exchange current, associated with Ca2+ release, can also contribute to EADs under adrenergic stimulation (Volders et al. 2000).

To study the TdP associated with cardiac remodelling, and the underlying cellular and molecular mechanisms, animal models have proven very useful. The dog with chronic atrioventricular block (cAVB) and biventricular hypertrophy has a high susceptibility to TdP-type arrhythmias and reiterates many characteristics of the clinical syndromes (Vos et al. 1998; van Opstal et al. 2001). At the cellular level, we observe hypertrophy and functional remodelling, with an increased susceptibility to EADs (Volders et al. 1998; Sipido et al. 2000). We postulated that loss of K+ currents forms the substrate for an increased incidence of EADs, which could be facilitated by an upregulated Na+–Ca2+ exchange current, in combination with increased sarcoplasmic reticulum (SR) Ca2+ release. Recently, Stengl et al. further emphasized how the lack of a significant increase in the slow delayed rectifier K+ current, IKs upon beta-adrenergic stimulation promotes EADs (Stengl et al. 2006). Although in a previous study (Sipido et al. 2000) we did not see differences in density of the peak inward ICaL in cAVB cells in basal conditions, it is possible that different kinetics or regulation of ICaL could contribute to the EADs under beta-adrenergic stimulation. Given the increased Ca2+ release in cAVB (Sipido et al. 2000), the Ca2+-dependent modulation of ICaL could also be altered in cAVB. In the current study we therefore investigated the properties of the Ca2+ current in cAVB myocytes, in particular its kinetics and its modulation by Ca2+ release from the SR at baseline and under beta-adrenergic stimulation.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Animal model and cell isolation

Total atrioventricular block was created in adult mongrel dogs of either sex (n = 9) as previously described (Vos et al. 1998). Animal handling was in accordance with the Dutch Law on Animal Experimentation and the European Directive for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (86/609/EU). At the time of sacrifice, AVB duration was 48 ± 7 days and weight 24 ± 1 kg; control animals were of matched weight (n = 7, 27 ± 2 kg). Dogs received full anaesthesia. After premedication (1 ml (5 kg)–1: 10 mg oxycodone HCl, 1 mg acepromazine and 0.5 mg atropine, I.M.), sodium pentobarbital (20 mg kg–1 I.V.) was given. Dogs were artificially ventilated with a mixture of oxygen, nitrous oxide (40:60%) and halothane (0.5–1% vapour concentration). Upon thoracotomy, heparin was administered I.V. The hearts were quickly excised and washed in cold cardioplegic solution. Heart weight/body weight was significantly larger in cAVB dogs (12.1 ± 0.4 g kg–1, versus 8.6 ± 0.3 g kg–1 in controls, P < 0.001). Single myocytes were enzymatically isolated from the midmyocardial layer of the left ventricular free wall, as previously described (Volders et al. 1998).

Experimental setup

The experimental setup was built around an inverted microscope (Nikon Diaphot) for simultaneous recording of ionic currents and of intracellular Ca2+ (Sipido et al. 2000). Cells were placed in a perfusion chamber and superfused with external solution at a flow rate of 4 ml min–1. Rapid changing of the extracellular solution was accomplished with a solution switcher, controlled by PClamp 8.0 software (Axon Instruments). The temperature of the bath was controlled and set at 37°C.

Membrane currents were recorded using the whole-cell ruptured patch-clamp technique; patch pipettes had a resistance of 1.5–2.5 M{Omega} when filled with internal solution. Membrane currents were recorded with an Axopatch 1D amplifier, filtered at 2 kHz, and sampled and digitized at 4 kHz using a Digidata 1200A analog-to-digital converter and pCLAMP 8.0 software (Axon Instruments). The data acquisition program also controlled the command potential. Membrane currents (pA) were normalized to cell capacitance (pF). The average cell capacity in controls was 169 ± 8 pF (30 cells) versus 182 ± 7 pF in cAVB (37 cells). The trend towards larger capacity was not statistically significant but within the same range as the values previously reported for larger groups, which were statistically significant: Verdonck et al. (2003) found capacitance values of 165 ± 5 pF (91 cells; 5 hearts) in control and 185 ± 4 pF (122 cells; 9 hearts) for cAVB.

In most of the experiments, the bulk changes in [Ca2+]i were buffered by inclusion of 1 mmol l–1 EGTA in the pipette solution. For some experiments, 80 µmol l–1 K5Fluo-3 was added to this pipette solution to report on the presence of Ca2+ release. In other experiments [Ca2+]i was not buffered, and we included 50 µmol l–1 K5Fluo-3 to a pipette solution without EGTA to record [Ca2+]i as previously described (Sipido et al. 2000), or loaded the cell with indo 1, through its ester form indo-1, AM (10 µmol l–1 for 10 min, followed by washing).

Solutions and experimental protocols

Cells were stored in normal Tyrode solution (mmol l–1): 137 NaCl, 5.4 KCl, 0.5 MgCl2, 1.8 CaCl2, 11.8 sodium Hepes and 10 glucose, pH 7.40. Whole-cell recording was established in this solution, but to measure Ca2+ currents we switched to a Na+- and K+-free solution containing (mmol l–1): 120 NMDGCl, 20 TEACl, 11 TEA-Hepes, 0.5 MgCl2, 1.8 CaCl2, 10 glucose, pH 7.4. The internal pipette solution contained (mmol l–1) 130 NMDGCl, 10 NMDG-Hepes, 0.5 MgCl2, 4 MgATP, 10 EGTA, pH 7.20. With these solutions there was a measured offset potential of 8–9 mV, true Vm being more positive than Vpipette. All potentials obtained in these solutions have been corrected in order to be able to compare data obtained in these conditions to data obtained in normal Tyrode solution.

Steady-state inactivation curves were constructed by normalizing the peak current at each test potential to the maximal current, and values were fitted with a Boltzmann equation: I/Imax = (1 – A)/{1 + exp[(VV1/2)/k]} + A; where V1/2 is the potential of half-maximal inactivation, k is the slope factor, A is the amplitude of the non-inactivating Ca2+ current. Activation curves were derived from current–voltage relations and described by: I/Imax = 1/{1 + exp[(V1/2V)/k]}. The dose–response curve for isoproterenol was fitted using a logistic equation of the form: I/I0 = Imax + (1 –Imax)/{1 + (EC50/[iso])n}, with EC50 being the concentration of isoproterenol at 50% activation, and n being the Hill coefficient.

For action potential recordings, the pipette solution contained (mmol l–1): 120 potassium aspartate, 20 KCl, 10 potassium Hepes, 10 NaCl, 4 MgATP, 0.05 K5Fluo-3, pH 7.20, and the external solution was normal Tyrode. To measure Ca2+ currents in the absence of Ca2+ buffering, EGTA was omitted from the pipette solution and NMDG+ was replaced by 120 Cs+ and 20 TEA+; in the external solution, NMDG+ was replaced by Na+, and 200 µmol l–1 lidocaine (lignocaine) was added to block the Na+ current.

Lidocaine and Cd2+ were prepared as 200 mmol l–1 stock solutions in water; Ni2+ was made as a 2.5 mol l–1 stock solution. Caffeine (10 mmol l–1) was directly dissolved into the external solution. Niflumic acid (100 mmol l–1) and nifedipine (10 mmol l–1) stock solutions were prepared in DMSO and diluted 1:1000 before use. Isoproterenol was prepared as a 3 mmol l–1 stock in water with 1 mmol l–1 ascorbic acid added; solutions were made freshly for each day of experiments.

Statistics

Data are shown as means ± S.E.M. and they were compared using Student's t test or two-way ANOVA; P < 0.05 was considered significant.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Properties of Ca2+ currents at baseline

The peak inward currents elicited from a holding voltage of –80 or –40 mV were identical, indicating there was no T-type current present, and values were not different between control (n = 15) and cAVB (n = 16) myocytes (Fig. 1). The current at the end of the 300 ms pulse (indicated by ‘x’) had similar amplitude in cAVB and control. The amplitude of this current was practically the same over the voltage range –20 to + 20 mV, i.e. the range in which the action potential plateau typically occurs.


Figure 1
View larger version (21K):
[in this window]
[in a new window]

 
Figure 1.  Amplitude of Ca2+ currents
A, voltage protocol to measure peak inward Ca2+ current from –40 and from –80 mV in a single recording. B, mean data for peak inward currents from 16 LV cells from 6 chronic AVB dogs and 15 LV cells from 5 control dogs, from both –40 and –80 mV holding potential. The current at the end of the pulse was the same regardless of the holding potential and is shown for a holding voltage of –40 mV. C, combined activation and inactivation curves; V1/2 of inactivation was –22 ± 2 mV and –27 ± 1 mV in cAVB versus control (P < 0.05), where k was 4.5 ± 0.3 mV in cAVB and 4.8 ± 0.3 mV in control (P = NS). For activation, V1/2 = –8 ± 2 mV, k = 4.5 ± 0.3 mV in cAVB; V1/2 = – 10 ± 1 mV, k = 4.9 ± 0.4 mV in control cells (P = NS).

 
Steady-state inactivation was studied during a test step to 0 mV following 2 s conditioning steps to potentials between –80 and +50 mV; the inactivation curve was shifted to the right by 5 mV in cAVB (V1/2 –22 ± 2, n = 9, versus –27 ± 1, n = 10, in control; P < 0.05). The combined inactivation and activation curves are shown in Fig. 1C. The voltage range and amplitude of window currents was compared as the overlapping area under the activation and inactivation curves between –50 and 0 mV (inset), and expressed as arbitrary units (a.u.); it was 3.5 ± 0.2 a.u. in cAVB and significantly larger than in control cells, where it was 2.7 ± 0.2 a.u.; the maximum was at –17 mV in control and at –13 mV in cAVB.

Faster inactivation of L-type Ca2+ current

Since we previously reported that the amplitude of sarcoplasmic reticulum Ca2+ release is larger in cAVB (Sipido et al. 2000), we measured the time course of inactivation of ICaL by fitting two exponentials to the decline of the current during a step to +10 mV. As illustrated in Fig. 2, the fast time constant was significantly shorter in cAVB. The amplitude of the fast declining current component was not significantly different for cAVB and control (71 ± 5% in cAVB versus 69 ± 3% in control).


Figure 2
View larger version (9K):
[in this window]
[in a new window]

 
Figure 2.  Time course of inactivation of the Ca2+ current at baseline
The current during a 300 ms step to +10 mV was fitted with two exponentials. The means for time constants are from 13 cells in each group.

 
Increase of ICaL by beta-adrenergic stimulation

We established a dose–response curve for beta-adrenergic increase of ICaL by washing in increasing concentrations of isoproterenol and measuring peak inward current during a test step to +10 mV. The peak current at each concentration was normalized to the baseline value. Figure 3A shows that the maximal increase at this potential was comparable for cAVB and control, with a Kd of 128 ± 38 nmol l–1 in control and 94 ± 13 nmol l–1 in cAVB (NS).


Figure 3
View larger version (15K):
[in this window]
[in a new window]

 
Figure 3.  beta-Adrenergic stimulation of Ca2+ current
A, dose–response for isoproterenol, of the peak inward current at +10 mV. The maximal response of the normalized current, I/I0, was 3.34 ± 1.18 and 3.47 ± 0.31, with EC50 of 94 ± 13 nM and 128 ± 38 nM in cAVB versus control (P = NS). The Hill coefficient was 1.42 ± 0.16 in cAVB and 1.38 ± 0.13 in control (P = NS). These parameters were calculated and averaged from individual fitting of data from 8 cAVB and 10 control cells. B, example of the wash-in of 3 µmol l–1 isoproterenol, illustrating the induction of inward current at –40 and –35 mV (arrows). C, nifedipine (blue trace) blocks all current from the holding voltage of –40 mV, but from the holding voltage of –80 mV residual current can be seen for the step to –20 mV. This residual current could be blocked with 200 µM Cd2+.

 
Figure 3B illustrates the washing of 3 µmol l–1 isoproterenol, the highest concentration tested, during a multiple step protocol that allowed following simultaneously the increase at the test potential of +10 mV and at –40 and –35 mV. The increase in current was very marked at these negative potentials (arrows), with current appearing where no inward current was present at baseline. We checked that all of the current we observed was L-type Ca2+ current. Nifedipine (10 µmol l–1) fully suppressed the current at –40 mV; however, at –20 mV, the current was suppressed for the depolarizing step from –40 mV, but not for the step from –80 mV, where a small current was left (Fig. 3C). This current was not T-type current, but resulted from unblock of nifedipine at –80 mV, consistent with the voltage dependence of nifedipine block and the decreased sensitivity of the channel in the presence of isoproterenol (Legssyer et al. 1997). Indeed, this current could not be blocked with 50 µM NiCl2 (n = 5), or with 100 µM lidocaine (n = 5), but it was nearly completely suppressed with 200 µM CdCl2 (n = 3).

When we examined the full range of the current–voltage relation from the two holding potentials at maximal stimulation by 3 µmol l–1 isoproterenol, we also found that the peak inward current was similar for the two holding voltages (Fig. 4A). A comparison between the I–V curves of cAVB (n = 12) and control (n = 10) yielded no statistical differences (ANOVA). However, the increase at the lower potentials was slightly less in cAVB (t test on data at –30 mV, P < 0.05). The I–V curves illustrate the leftward shift of activation. Steady-state inactivation curves were also shifted to the left and inactivation was incomplete even at 0 mV. Figure 4B shows the pooled data for steady-state inactivation and activation. The window area was much larger than in baseline conditions (Fig. 1C). The calculated surface area was 6.8 ± 0.8 (n = 7) in cAVB, not significantly different from the value in control cells (6.3 ± 0.4, n = 8). However the position of both activation and inactivation curves in cAVB was significantly more to the right resulting in a more positive maximum (–27 mV in cAVB, and –32 mV in control).


Figure 4
View larger version (25K):
[in this window]
[in a new window]

 
Figure 4.  Current–voltage relation and inactivation under beta-adrenergic stimulation
A, full I–V curves from holding potential of –80 and –40 mV, mean data for 12 cAVB cells and 10 control cells. B, pooled data for steady-state inactivation and activation illustrating the window current range; V1/2 values were (in cAVB versus control): for inactivation, –30 ± 1 versus –35 ± 1 mV; for activation, –25 ± 1 versus –30 ± 1 mV (both P < 0.05). Slope was k = 4.3 ± 0.4 versus 4.4 ± 0.1 for inactivation; k = 3.9 ± 0.4 versus 3.3 ± 0.2 for activation (cAVB versus control, P = NS). The inset is an enlargement of the window area.

 
Figure 5A illustrates in an example the presence of window current at –35 mV. Independent of the preceding voltage step, which was varied between –80, –40 and 0 mV, a similar end current level was reached with a clear recovery of current on repolarization from 0 mV into the window. Figure 5B illustrates that in the absence of [Ca2+]i buffering we could see a similar recovery of current at –35 mV on repolarization. This experiment also shows that the persistent inward current at –35 mV was accompanied by a sustained Ca2+ influx. For the step from –10 to –35 mV, [Ca2+]i has a brief decline and increase before reaching a steady state, compatible with reactivation in the window voltage. Figure 5C illustrates data obtained with the ratiometric Ca2+ indicator, indo-1, confirming these observations. During this 18 s step, a 5 s application of 200 µM CdCl2 suppressed both inward current and Ca2+ influx, confirming both result from Ca2+ window current (similar data in 5 cells).


Figure 5
View larger version (16K):
[in this window]
[in a new window]

 
Figure 5.  Window currents under beta-adrenergic stimulation
A, illustration of the window current at –35 mV. The current at the end of a 1.5 s depolarizing step is independent of the preceding voltage: for a negative conditioning pulse one can see activation and partial inactivation (blue trace, –80 mV), whereas for a positive conditioning step there is recovery from inactivation (black trace, 0 mV). B, window current (upper panel) and Ca2+ influx measured with Fluo-3 (lower panel), in a cell dialysed without EGTA. C, the window current (upper panel) and [Ca2+]i (lower panel) measured during a 18 s step at –35 mV following a pulse to –10 mV at baseline (black traces); during the next sweep, 200 µM Cd2+ applied for 5 s transiently blocked the persistent inward current and Ca2+ influx, with full recovery on washout (red traces). [Ca2+]i was measured using Indo-1.

 
A striking feature of the current at –35 mV, when evoked from –80 mV with full availability of Ca2+ channels, was the presence of a transient reduction in the inward current immediately after the peak, resulting in a ‘notch’ (Fig 5A, blue trace, arrow). This was not observed at baseline and was not sensitive to a Cl channel blocker (100 µmol l–1 niflumic acid, n = 7), but it was suppressed by nifedipine, suggesting it is an integral part of the Ca2+ current. We postulated that it resulted from modulation of the Ca2+ current by Ca2+ release from the sarcoplasmic reticulum (SR), not buffered by EGTA.

Modulation of window current by SR Ca2+ release

To further study and quantify this postulated inactivation and recovery process, we used the voltage protocol illustrated in Fig. 6A. A step to 0 mV was introduced at varying time intervals after the step to –35 mV, to examine the availability of L-type Ca2+ channels. The evolution of the peak of the current at 0 mV then reflects the time course of inactivation and recovery. This time course tracked closely the ‘notch’ on the current trace at –35 mV. A quantitative analysis of the correlation between the peak current at 0 mV, normalized to its maximal value, and the corresponding current at –35 mV, also normalized to its maximal value, yielded a correlation coefficient of 0.94 ± 0.01, with P < 0.001 (illustrated in Fig. 6C). These data are consistent with our hypothesis that the ‘notch’ results from an inactivation and recovery process.


Figure 6
View larger version (24K):
[in this window]
[in a new window]

 
Figure 6.  Time course of inactivation and recovery during a single depolarizing step
A, left panels, the ‘notch’ on the current during a step to –35 mV is reflected in the availability of L-type Ca2+ channels, as tested during a further depolarizing step to 0 mV. A spike of fluorescence was also recorded. However this was not present at baseline in the absence of isoproterenol (right panel). B, after addition of caffeine to suppress sarcoplasmic reticulum (SR) Ca2+ release and uptake, the notch disappeared and one saw only monotonous inactivation during the step, reflected also in the time course of the peak current for steps to 0 mV. C, comparison of the time course of the window current and the peak inward current at 0 mV: left panel, measured data points; middle panel, values after normalization to the maximal peak inward current; right panel, correlation analysis and regression (r = 0.96, P < 0.001, slope 1.18).

 
To see whether this was indeed related to SR Ca2+ release, we added a Ca2+ indicator to the pipette solution. In the presence of high EGTA, a slow Ca2+ buffer, this will still report on the release process, following the time course of the derivative of the [Ca2+]i transient rather than the time course of [Ca2+]i (Sham et al. 1995, 1998). As illustrated in Fig. 6A we indeed saw a spike of fluorescence immediately following the depolarization. The right panel shows that neither the ‘notch’, the modulation of peak current at 0 mV, nor the Ca2+ spike were present in the absence of isoproterenol (similar observations in seven cells).

We further examined the role of SR Ca2+ release by analysing the time course of the Ca2+ window current after suppressing SR Ca2+ release by continuous superfusion of the cells with 10 mmol l–1 caffeine (Fig. 6B). In the presence of caffeine there was no ‘notch’ on the current trace at –35 mV, and the test pulses to 0 mV showed a monotonous inactivation (n = 5). The inactivation at the end of the pulse was actually more pronounced than in the absence of caffeine, probably because of larger cytosolic Ca2+ accumulation during Ca2+ influx as there is no effective SR Ca2+ uptake.

Using this protocol on cells from cAVB (n = 10) and control (n = 9), we saw the typical inactivation and recovery in both groups. To quantify the extent of this modulation, we measured the ratio between the fully available current at 0 mV, Imax, and the minimal current at 25 ms, i.e. the extent of inactivation, and the ratio between Imax and the subsequent maximally recovered current. The difference between these two measurements then indicates the extent of dynamic modulation. As illustrated in Fig. 7, this was significantly larger in cAVB than in control myocytes (23 ± 2% of the initially available current, versus 13 ± 3% in control; P < 0.05).


Figure 7
View larger version (17K):
[in this window]
[in a new window]

 
Figure 7.  Dynamic modulation of the L-type Ca2+ current is larger in cAVB
The extent of this modulation was quantified by measuring the ratio between the maximal current at 0 mV, Imax, and the minimal current at 25 or 50 ms, i.e. inactivation, and between Imax and the subsequent maximal current, i.e. recovery. Inactivation tended to be larger in cAVB as did the recovery, such that the extent of modulation, i.e. the difference between inactivation and recovery was significantly larger in cAVB than in control myocytes (n = 9 for control and 10 for cAVB).

 
Modulation of Ca2+ current in the absence of Ca2+ buffering

Our data on the current modulation so far were obtained in the presence of EGTA and indicated that it is the subsarcolemmal Ca2+ that drives this process. In a number of cells we confirmed that similar processes were present in the absence of Ca2+ buffering. Such experiments are more difficult to interpret as we can not work in Na+-free conditions and Na+ and Na+–Ca2+ exchange currents superimpose on Ca2+currents. To suppress the Na+ current we used a holding voltage of –65 mV and added 200 µM lidocaine. Figure 8A illustrates the inactivation/recovery time course of the current at –35 mV and its relation to the global [Ca2+]i transient in a cAVB myocyte. The current at –35 mV (trace indicated by arrow and labelled ‘a’) now did not have a ‘notch’ but had a transient inward current, presumably Na+/Ca2+ exchange current. The test pulses to 0 mV however, had a time course very similar as in the presence of EGTA with a clear inhibition at 20 ms, with subsequent partial recovery; the inhibition occurred at the same time as the inward current on the trace at –35 mV. The [Ca2+]i transient corresponding to the pulse to –35 mV (black trace, ‘a’) attained a peak value at 40 ms after the onset of the depolarization, slightly lagging behind the maximal inhibition of the current; the decline of the global [Ca2+]i transient was also slower than the recovery of the current as derived from the evolution of the peak current with the test pulse to 0 mV. This protocol was applied to four cAVB cells and five control cells, and the dynamic modulation of the Ca2+ current was analysed. As shown in Fig. 8B, without Ca2+ buffering, the extent of inactivation tended to be larger in cAVB with a significantly larger dynamic modulation than in control (25 ± 7% of the initially available current, versus 8 ± 2% in control; P < 0.05).


Figure 8
View larger version (23K):
[in this window]
[in a new window]

 
Figure 8.  Dynamic modulation in the absence of [Ca2+]i buffering
A, example of simultaneous recording of membrane currents and [Ca2+]i. The trace labelled ‘a’ is the step from –80 to –35 mV; ‘b’ and ‘c’ are the test steps to 0 mV at 0 and 20 ms. B, pooled data of 5 control and 4 cAVB myocytes for the extent of inactivation, recovery and modulation, see legend to Fig. 7.

 
These data confirm that the Ca2+ channel undergoes a pronounced inactivation and recovery process driven by changes in Ca2+ near the membrane during SR Ca2+ release, and this is larger in myocytes from cAVB.

Properties of EADs in cAVB

The experiments above do not examine directly the current underlying EADs in cAVB. However, the data support the potential and likelihood for Ca2+ current being involved in EADs under beta-adrenergic stimulation, as recovery from inactivation by SR Ca2+ release of the Ca2+ current could contribute a net depolarization and EAD. This hypothesis predicts that EADs are most likely to be observed in the voltage range of the window currents and at a time when the Ca2+ transient has declined substantially. We examined these predictions in two series of experiments. In myocytes studied with microelectrodes, EADs were observed in 4/13 cells in the presence of 300 nmol l–1 isoproterenol and the EAD take-off potential was –35 ± 4 mV, within the range of the maximal window current. In another group of cAVB myocytes we recorded action potentials and [Ca2+]i transients under whole-cell voltage clamp, in the presence of 1 µmol l–1 isoproterenol and stimulated at 0.5 Hz; EADs were observed in 4/10 cells. As illustrated in Fig. 9, in these conditions the [Ca2+]i transient had declined to near baseline values, even at plateau potentials, before the appearance of EADs (at 800–1200 ms after the upstroke of the action potential, [Ca2+]i had declined to 5–10% of its peak value; take-off potential was between –40 and –10 mV). In the example, the EAD was accompanied by a modest increase in [Ca2+]i, whereas the subsequent DAD was accompanied by a large spontaneous increase of [Ca2+]i. These observations are consistent with the concept that under beta-adrenergic stimulation window currents could contribute to EADs following recovery of ICaL from Ca2+-release-dependent inactivation.


Figure 9
View larger version (19K):
[in this window]
[in a new window]

 
Figure 9.  Early afterdepolarization and [Ca2+]i
Example of action potentials and [Ca2+]i transients recorded in a cAVB myocyte in the presence of 1 µmol l–1 isoproterenol. The early afterdepolarization (EAD) is accompanied by an increase of [Ca2+]i that is, however, small compared with the [Ca2+]i transients that arise spontaneously at the resting membrane potential 3 s later. Just before the last stimulated action potential, a spontaneous release occurs, with a small depolarization, reducing the triggered Ca2+ release.

 

    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Chronic AVB leads to extensive remodelling and myocyte hypertrophy at 6 weeks; at this time contractile function is preserved but there is an enhanced susceptibility for arrhythmias (Volders et al. 1998; de Groot et al. 2000). In the present report we examined potential changes in Ca2+ current properties that could contribute to this pro-arrhythmia.

Baseline amplitude of Ca2+ currents is unchanged in cAVB but window area is increased

We first established that there was no re-expression of T-type Ca2+ current as described in other models of cardiac remodelling in the dog (Dun et al. 2004).

We next focused on the properties of the L-type Ca2+ current and found that the amplitude of peak currents at baseline was unchanged in cAVB, but that the inactivation curve was shifted to the right and the area of window currents increased. A comparison to the literature shows that the whole-cell L-type Ca2+ current is unchanged in many models of hypertrophy (Tomaselli & Marban, 1999), but that in some models the current is increased, at least transiently (Balke & Shorofsky, 1998; Perrier et al. 2004), sometimes with larger window currents (Ryder et al. 1993). Such data do not necessarily imply that the expression and function of the channels is unchanged. In human heart failure an interesting story has unfolded, as single-channel recordings have indicated that the activity of the individual channels is increased (Schroder et al. 1998). Cheng et al. showed that PKA activation resulted in smaller maximal currents in failing myocytes, suggesting a higher phosphorylation level at baseline (Chen et al. 2002), which could compensate for either a lower number of channels, or a reduced open probability due to altered subunit expression (Hullin et al. 2003). In the present study, a higher level of baseline phosphorylation could help to explain why the whole-cell current is normal despite a downregulation of transcription of the {alpha} subunit in the LV free wall (Ramakers et al. 2005). The somewhat smaller response of peak ICaL to isoproterenol in the negative voltage range and the reduced leftward shift of the activation and inactivation curves could be consistent with this hypothesis. This remains, however, speculative at present and needs to be further investigated.

This hypothesis also does not address why we see a rightward shift of the inactivation curve at baseline. We could not detect this in an earlier series of experiments, which examined a different population and a smaller sample (Sipido et al. 2000). Auxilliary beta subunits are known to affect the rate of inactivation, as well as levels of functional expression (Takahashi et al. 2003). At present little is known about changes in beta subunits with remodelling, but we plan to further investigate this potential mechanism.

Modulation of L-type Ca2+ current by Ca2+ release from the SR

Earlier studies have underscored the importance of the inactivation of L-type Ca2+ current by the high local concentration of Ca2+ during Ca2+ release from the SR (Sham et al. 1995; Sipido et al. 1995; Adachi Akahane et al. 1996) and the role of release-dependent inactivation of ICaL on the AP plateau and duration (Fauconnier et al. 2003; Takamatsu et al. 2003). The emphasis in the present study is on the recovery following inactivation and the consequent dynamic modulation of currents in the window voltage, an aspect that has received less attention before. In an earlier study we demonstrated the recovery by subtraction analysis of two pulses with different amplitudes of Ca2+ release (Sipido et al. 1995). Using the novel protocol of the present study we could follow the time course throughout a single pulse. A limitation of the current protocol is that we can apply it only for smaller depolarizing steps, but it is well suited to study the window current voltage range. A major advantage is that it can also be applied to examine inactivation and recovery with Na+ present in the external solution. The protocol clearly demonstrates that the time course of the net current in the presence of Na+ does not reveal the extent of inactivation and recovery of the Ca2+ channels due to superimposition of the Na+–Ca2+ exchange current.

With this approach we thus find a small but significant increase in the amplitude of the modulation of the Ca2+ current by SR Ca2+ release in cAVB. This distinguishes the remodelling in the dog with cAVB and compensated hypertrophy from the changes in the dog with heart failure where Ca2+ release from the SR is reduced and Ca2+ current inactivation is slower (O'Rourke et al. 1999; Winslow et al. 1999). The data are also consistent with a preserved Ca2+ removal process in cAVB, necessary to observe recovery of ICaL, again different from the reduced Ca2+ uptake into the SR observed in heart failure (reviewed in Hasenfuss & Pieske, 2002). The extent of inactivation and recovery is only slightly less in the presence of EGTA compared to without Ca2+ buffering, indicating that it results from a local process which is unaffected by buffering of bulk changes in [Ca2+]i and consistent with data from others (Sham et al. 1995; Adachi Akahane et al. 1996).

We did not formally study the relative contribution of Na+–Ca2+ exchange inward current compared to inward current resulting from recovery from inactivation of ICaL. Data in Fig. 8A, and published data on the time course of Na+–Ca2+ exchange during caffeine-induced Ca2+ release, support the hypothesis that these are consecutive events. On activation of Ca2+ release Na+–Ca2+ exchange inward current is large and ICaL is small because of inactivation; on Ca2+ reuptake into the SR, Na+–Ca2+ exchange current wanes and ICaL recovers. Inward Na+–Ca2+ exchange current and ICaL can thus both contribute to EADs, the former by a ‘conditioning phase’ of depolarization during Ca2+ release (Volders et al. 2000), followed by reactivation of ICaL.

Mechanisms of EADs and adrenergic response of Ca2+ current in cAVB

The small rightward shift of the inactivation curve in cAVB does not affect availability of the current at baseline, but can enhance availability during the plateau. It notably leads to a larger window for current re-activation, and this finding could be relevant for the EADs that occur in the presence of IKr block with dofetilide or almokalant (Volders et al. 1998). Another property of ICaL in cAVB that will facilitate EADs at plateau voltages is the small rightward shift of the maximal window current observed in the presence of beta-adrenergic stimulation.

The response of ICaL to beta-adrenergic stimulation is largely preserved, even if the peak amplitude at more negative potentials is somewhat smaller. On a background of reduced repolarizing current (Volders et al. 1999), in particular IKs which should shorten the action potential under beta-adrenergic stimulation (Varro et al. 2000; Stengl et al. 2003; Jost et al. 2005), the preserved ICaL is an important factor in tipping the balance towards action potential prolongation and EAD formation.

As recently demonstrated in an elegant modelling study (Tanskanen et al. 2005), the mode 2 gating of Ca2+ channels under beta-adrenergic stimulation and the stochastic nature of the channel behaviour can explain the occurrence of EADs within a typical pattern of variable duration of the action potential, as we also observed (Fig. 9). Our data add direct evidence for the recovery of the Ca2+ current during maintained depolarization. The extent of recovery we measure is actually larger than proposed in modelling; this can be due to local [Ca2+]i changes being larger than provided for in the modelling or because the model implements only a limited number of release units.

Though most of the work on the recovery in the present study was done at –35 mV, equally large sustained currents are present at more positive potentials (Fig. 4). We have previously shown that the modulation of ICaL by SR Ca2+ release is not voltage dependent (Sipido et al. 1995), consistent with the location of the Ca2+-binding site in the cytosolic carboxytail of the channel (Peterson et al. 2000). This implies that a similar extent of recovery can also occur at the more positive potentials.

In conclusion, in cAVB, the L-type Ca2+ current has a larger window; with beta-adrenergic stimulation it occurs at more positive voltages than in the control; the Ca2+ current has an enhanced dynamic modulation related to the large amplitude of SR Ca2+ release. These properties may contribute to the availability of Ca2+ channels and the increased incidence of EADs in cAVB under beta-adrenergic stimulation.


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Adachi Akahane S, Cleemann L & Morad M (1996). Cross-signaling between L-type Ca2+ channels and ryanodine receptors in rat ventricular myocytes. J Gen Physiol 108, 435–454.[Abstract/Free Full Text]

Antzelevitch C & Shimizu W (2002). Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol 17, 43–51.[CrossRef][Medline]

Balke CW & Shorofsky S (1998). Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc Res 37, 290–299.[Abstract/Free Full Text]

Boutjdir M, Restivo M, Wei Y, Stergiopoulos K & el Sherif N (1994). Early afterdepolarization formation in cardiac myocytes: analysis of phase plane patterns, action potential, and membrane currents. J Cardiovasc Electrophysiol 5, 609–620.[Medline]

Chen X, Piacentino V, Furukawa S, Goldman B, Margulies KB & Houser SR (2002). L-type Ca2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices. Circ Res 91, 517–524.[Abstract/Free Full Text]

Dun W, Baba S, Yagi T & Boyden PA (2004). Dynamic remodeling of K+ and Ca2+ currents in cells that survived in the epicardial border zone of canine healed infarcted heart. Am J Physiol Heart Circ Physiol 287, H1046–H1054.[Abstract/Free Full Text]

Fauconnier J, Bedut S, Le Guennec JY, Babuty D & Richard S (2003). Ca2+ current-mediated regulation of action potential by pacing rate in rat ventricular myocytes. Cardiovasc Res 57, 670–680.[Abstract/Free Full Text]

de Groot SH, Schoenmakers M, Molenschot MM, Leunissen JD, Wellens HJ & Vos MA (2000). Contractile adaptations preserving cardiac output predispose the hypertrophied canine heart to delayed afterdepolarization-dependent ventricular arrhythmias. Circulation 102, 2145–2151.[Abstract/Free Full Text]

Hasenfuss G & Pieske B (2002). Calcium cycling in congestive heart failure. J Mol Cell Cardiol 34, 951–969.[CrossRef][Medline]

Hullin R, Khan IF, Wirtz S, Mohacsi P, Varadi G, Schwartz A & Herzig S (2003). Cardiac L-type calcium channel beta-subunits expressed in human heart have differential effects on single channel characteristics. J Biol Chem 278, 21623–21630.[Abstract/Free Full Text]

Janse MJ (2004). Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 61, 208–217.[Abstract/Free Full Text]

January CT & Riddle JM (1989). Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current. Circ Res 64, 977–990.[Abstract/Free Full Text]

Jost N, Virag L, Bitay M, Takacs J, Lengyel C, Biliczki P, Nagy Z, Bogats G, Lathrop DA, Papp JG & Varro A (2005). Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle. Circulation 112, 1392–1399.[Abstract/Free Full Text]

Legssyer AK, Hove-Madsen L, Hoerter J & Fischmeister R (1997). Sympathetic modulation of the effect of nifedipine on myocardial contraction and Ca current in the rat. J Mol Cell Cardiol 29, 579–591.[CrossRef][Medline]

O'Rourke B, Kass DA, Tomaselli GF, Kaab S, Tunin R & Marban E (1999). Mechanisms of altered excitation–contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ Res 84, 562–570.[Abstract/Free Full Text]

van Opstal JM, Verduyn SC, Leunissen HD, de Groot SH, Wellens HJ & Vos MA (2001). Electrophysiological parameters indicative of sudden cardiac death in the dog with chronic complete AV-block. Cardiovasc Res 50, 354–361.[Abstract/Free Full Text]

Perrier E, Kerfant BG, Lalevee N, Bideaux P, Rossier MF, Richard S, Gomez AM & Benitah JP (2004). Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction. Circulation 110, 776–783.[Abstract/Free Full Text]

Peterson BZ, Lee JS, Mulle JG, Wang Y, de Leon M & Yue DT (2000). Critical determinants of Ca2+-dependent inactivation within an EF-hand motif of L-type Ca2+ channels. Biophys J 78, 1906–1920.[Abstract/Free Full Text]

Pogwizd SM, Hoyt RH, Saffitz JE, Corr PB, Cox JL & Cain ME (1992). Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 86, 1872–1887.[Abstract/Free Full Text]

Puglisi JL, Yuan W, Bassani JW & Bers DM (1999). Ca2+ influx through Ca2+ channels in rabbit ventricular myocytes during action potential clamp: influence of temperature. Circ Res 85, e7–e16.[Abstract/Free Full Text]

Ramakers C, Volders PGA, Donker DW, Beekman JD, Moorman AF & Vos MA (2005). Downregulation of ion channel subunits underlying electrical remodeling in the dog with complete atrio-ventricular block: regional and temporal considerations. Heart Rhythm 2, S7.

Ryder KO, Bryant SM & Hart G (1993). Membrane current changes in left ventricular myocytes isolated from guinea pigs after abdominal aortic coarctation. Cardiovasc Res 27, 1278–1287.[Abstract/Free Full Text]

Schroder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L, Schwinger RH, Weil J & Herzig S (1998). Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation 98, 969–976.[Abstract/Free Full Text]

Sham JSK, Cleemann L & Morad M (1995). Functional coupling of Ca2+ channels and ryanodine receptors in cardiac myocytes. Proc Natl Acad Sci U S A 92, 121–125.[Abstract/Free Full Text]

Sham JS, Song LS, Chen Y, Deng LH, Stern MD, Lakatta EG & Cheng H (1998). Termination of Ca2+ release by a local inactivation of ryanodine receptors in cardiac myocytes. Proc Natl Acad Sci U S A 95, 15096–15101.[Abstract/Free Full Text]

Sipido KR, Callewaert G & Carmeliet E (1995). Inhibition and rapid recovery of ICa during calcium release from the sarcoplasmic reticulum in guinea-pig ventricular myocytes. Circ Res 76, 102–109.[Abstract/Free Full Text]

Sipido KR, Volders PGA, de Groot SH, Verdonck F, Van de Werf F, Wellens HJ & Vos MA (2000). Enhanced Ca2+ release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: a potential link between contractile adaptation and arrhythmogenesis. Circulation 102, 2137–2144.[Abstract/Free Full Text]

Stengl M, Ramakers C, Donker DW, Nabar A, Rybin AV, Spätjens RL, van der Nagel T, Wodzig WK, Sipido KR, Antoons G, Moorman AF, Vos MA & Volders PG (2006). Temporal patterns of electrical remodeling in canine ventricular hypertrophy: focus on IKs downregulation and blunted beta-adrenergic activation. Cardiovasc Res 72, 90–100.[Abstract/Free Full Text]

Stengl M, Volders PG, Thomsen MB, Spatjens RL, Sipido KR & Vos MA (2003). Accumulation of slowly activating delayed rectifier potassium current (IKs) in canine ventricular myocytes. J Physiol 551, 777–786.[Abstract/Free Full Text]

Studenik CR, Zhou Z & January CT (2001). Differences in action potential and early afterdepolarization properties in LQT2 and LQT3 models of long QT syndrome. Br J Pharmacol 132, 85–92.[CrossRef][Medline]

Takahashi SX, Mittman S & Colecraft HM (2003). Distinctive modulatory effects of five human auxiliary beta2 subunit splice variants on L-type calcium channel gating. Biophys J 84, 3007–3021.[Abstract/Free Full Text]

Takamatsu H, Nagao T, Ichijo H & Adachi-Akahane S (2003). L-type Ca2+ channels serve as a sensor of the SR Ca2+ for tuning the efficacy of Ca2+-induced Ca2+ release in rat ventricular myocytes. J Physiol 552, 415–424.[Abstract/Free Full Text]

Tanskanen AJ, Greenstein JL, O'Rourke B & Winslow RL (2005). The role of stochastic and modal gating of cardiac L-type Ca2+ channels on early after-depolarizations. Biophys J 88, 85–95.[Abstract/Free Full Text]

Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, Kass D, Feldman AM & Marban E (1994). Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation 90, 2534–2539.[Abstract/Free Full Text]

Tomaselli GF & Marban E (1999). Electrical remodeling in hypertrophy and heart failure. Cardiovasc Res 42, 270–284.[Free Full Text]

Varro A, Balati B, Iost N, Takacs J, Virag L, Lathrop DA, Csaba L, Talosi L & Papp JG (2000). The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization. J Physiol 523, 67–81.[Abstract/Free Full Text]

Verdonck F, Volders PGA, Vos MA & Sipido KR (2003). Increased Na+ concentration and altered Na/K pump activity in hypertrophied canine ventricular cells. Cardiovasc Res 57, 1035–1043.[Abstract/Free Full Text]

Volders PGA, Sipido KR, Vos MA, Kulcsar A, Verduyn SC & Wellens HJJ (1998). Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 98, 1136–1147.[Abstract/Free Full Text]

Volders PGA, Sipido KR, Vos MA, Spätjens RLHMG, Leunissen-Beekman JDM, Carmeliet E & Wellens HJJ (1999). Downregulation of delayed rectifier K+ currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 100, 2455–2461.[Abstract/Free Full Text]

Volders PG, Vos MA, Szabo B, Sipido KR, de Groot SH, Gorgels AP, Wellens HJ & Lazzara R (2000). Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc Res 46, 376–392.[Free Full Text]

Vos MA, de Groot SH, Verduyn SC, van der Zande J, Leunissen HD, Cleutjens JP, van Bilsen M, Daemen MJ, Schreuder JJ, Allessie MA & Wellens HJ (1998). Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 98, 1125–1135.[Abstract/Free Full Text]

Vos MA & Paulussen AD (2004). Genetic basis of drug-induced arrhythmias. Ann Med 36, 35–40.[CrossRef][Medline]

Winslow RL, Rice JJ, Jafri S, Marban E & O'Rourke B (1999). Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. Circ Res 84, 571–586.[Abstract/Free Full Text]

Yan GX, Wu Y, Liu T, Wang J, Marinchak RA & Kowey PR (2001). Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall. Circulation 103, 2851–2856.[Abstract/Free Full Text]

Zipes DP & Wellens HJJ (1998). Sudden cardiac death. Circulation 98, 2334–2351.[Free Full Text]


    Acknowledgements
 
The study was supported by a grant to K.R.S. from the FWO, the Fund for Scientific Research, Flanders (G. 0166.03N) and from the EU FP6 (LSHM-CT-2005-018833, EUGeneHeart), and by a grant from The Netherlands Organization for Scientific Research, NWO (916.56.145) to G. Antoons. The authors wish to thank Johan Vereecke for helpful discussions.




This article has been cited by other articles:


Home page
EuropaceHome page
G. Antoons and K. R. Sipido
Targeting calcium handling in arrhythmias
Europace, December 1, 2008; 10(12): 1364 - 1369.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Bito, F. R. Heinzel, L. Biesmans, G. Antoons, and K. R. Sipido
Crosstalk between L-type Ca2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling
Cardiovasc Res, January 15, 2008; 77(2): 315 - 324.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
579/1/147    most recent
jphysiol.2006.124222v2
jphysiol.2006.124222v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antoons, G.
Right arrow Articles by Sipido, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antoons, G.
Right arrow Articles by Sipido, K. R.
Related Collections
Right arrow Cardiovascular